Bosh sahifaLSTA • NASDAQ
add
Lisata Therapeutics Inc
Yopilish kursi
2,77 $
Kunlik diapazon
2,65 $ - 2,82 $
Yillik diapazon
1,87 $ - 4,20 $
Bozor kapitalizatsiyasi
23,69 mln USD
Oʻrtacha hajm
51,24 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 70,00 ming | — |
Joriy xarajat | 4,94 mln | -10,59% |
Sof foyda | -4,66 mln | 7,63% |
Sof foyda marjasi | -6,66 ming | — |
Har bir ulushga tushum | -0,54 | 11,48% |
EBITDA | -4,82 mln | 11,94% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 21,97 mln | -42,58% |
Jami aktivlari | 25,16 mln | -40,90% |
Jami passivlari | 4,38 mln | -4,17% |
Umumiy kapital | 20,78 mln | — |
Tarqatilgan aksiyalar | 8,76 mln | — |
Narxi/balansdagi bahosi | 1,14 | — |
Aktivlardan daromad | -44,96% | — |
Kapitaldan daromad | -52,95% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -4,66 mln | 7,63% |
Operatsiyalardan naqd pul | -3,96 mln | 25,12% |
Sarmoyadan naqd pul | 505,00 ming | -95,69% |
Moliyadan naqd pul | 64,00 ming | 100,00% |
Naqd pulning sof oʻzgarishi | -3,38 mln | -152,13% |
Boʻsh pul | -2,53 mln | 28,81% |
Haqida
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Tashkil etilgan
1980
Sayt
Xodimlar soni
26
